300 related articles for article (PubMed ID: 33859755)
1. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
2. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
3. Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy.
Gao Z; He T; Zhang P; Li X; Zhang Y; Lin J; Hao J; Huang P; Cui J
ACS Appl Mater Interfaces; 2020 May; 12(18):20271-20280. PubMed ID: 32283924
[TBL] [Abstract][Full Text] [Related]
4. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
[TBL] [Abstract][Full Text] [Related]
5. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
6. MOF-based nanozyme grafted with cooperative Pt(IV) prodrug for synergistic anticancer therapy.
Wu PH; Cheng PF; Kaveevivitchai W; Chen TH
Colloids Surf B Biointerfaces; 2023 May; 225():113264. PubMed ID: 36921426
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
[TBL] [Abstract][Full Text] [Related]
8. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction.
Hu H; Zheng S; He C; Zheng Y; Wei Q; Chen S; Wu Z; Xu Y; Zhao B; Yan C
J Nanobiotechnology; 2024 May; 22(1):234. PubMed ID: 38724978
[TBL] [Abstract][Full Text] [Related]
10. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
[TBL] [Abstract][Full Text] [Related]
12. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
13. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.
Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941
[TBL] [Abstract][Full Text] [Related]
14. Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis.
Zhou QM; Lu YF; Zhou JP; Yang XY; Wang XJ; Yu JN; Du YZ; Yu RS
J Nanobiotechnology; 2021 Nov; 19(1):361. PubMed ID: 34749740
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy.
Zheng Y; Qin C; Li F; Qi J; Chu X; Li H; Shi T; Yan Z; Yang L; Xin X; Liu L; Han X; Yin L
Biomater Sci; 2023 May; 11(9):3321-3334. PubMed ID: 36946490
[TBL] [Abstract][Full Text] [Related]
16. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy.
Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q
J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Manganese Oxide Sweetgum-Ball Nanospheres with Large Mesopores Regulate Tumor Microenvironments for Enhanced Tumor Nanotheranostics.
Feng Y; Ding D; Sun W; Qiu Y; Luo L; Shi T; Meng S; Chen X; Chen H
ACS Appl Mater Interfaces; 2019 Oct; 11(41):37461-37470. PubMed ID: 31577423
[TBL] [Abstract][Full Text] [Related]
18. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
19. A Dual Stimuli-Responsive Nanoplatform Loaded Pt
Fang K; Sun Y; Yang J; Hu X; Chen M; Li R; Yang X; Fan T; Wu J; Tong X; Dong C; Shi S
Adv Healthc Mater; 2023 Nov; 12(28):e2301328. PubMed ID: 37392128
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
